Skip to main content
Clinical Trials/NCT05737550
NCT05737550
Completed
Not Applicable

A Second Explorative Pilot Study Evaluating Usability and Functionality of a New Mobile Phone Application Measuring Eye Parameters of Eyes in Patients With Confirmed Substance Use Disorder (SUD)

Kontigo Care AB1 site in 1 country24 target enrollmentMarch 10, 2023
ConditionsDrug Abuse

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Drug Abuse
Sponsor
Kontigo Care AB
Enrollment
24
Locations
1
Primary Endpoint
Usability Questionnaire - Question 1.
Status
Completed
Last Updated
last year

Overview

Brief Summary

This will be a pre-market, explorative, early feasibility, pilot, controlled clinical investigation designed to collect initial clinical data for Previct Drugs.

Detailed Description

This second early feasibility study will give valuable information on the usability of Previct Drugs once being used in the intended population, i.e, patients with confirmed Substance Use Disorder (SUD). It will also give valuable information on the feasibility of Previct drugs function to measure pupils and eye movements in this population including evaluating the safety when using the device.

Registry
clinicaltrials.gov
Start Date
March 10, 2023
End Date
June 28, 2023
Last Updated
last year
Study Type
Interventional
Study Design
Single Group
Sex
All

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • Signed Informed Consent Form
  • Male and female
  • A recurrent visitor at Sprututbytesprogrammet in Uppsala defined as visited the clinic within the last three (3) months
  • SUD in accordanve with DSM-5 criteria according to investigator/designee judgement
  • Age 18 and above
  • Negative urine pregnancy test for all fertile women
  • Been informed of the nature, the scope, and the relevance of the clinical investigation
  • Voluntarily agreed on participation and has duly singed the Informed Consent Form

Exclusion Criteria

  • Participating in another clinical investigation which may affect the study outcome according to clinical judgement
  • Pregnancy or lactating
  • Any ECG dangerous arrythmia according to the investigator or designee judgement
  • Any disease or condition that may influence pupillary reflexes based on clinical judgement
  • Undergone eye surgery that may influence pupillary reflexes based on clinical judgement
  • Not able to read or understand the local language
  • Any planned travel or treatment which will make it impossible to participate according to the investigator or designee
  • Any other condition that as judged by the investigator may make the follow-up or investigation inappropriate
  • That according to the Declaration of Helsinki is deemed unsuitable for study enrolment

Outcomes

Primary Outcomes

Usability Questionnaire - Question 1.

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 1. Please evaluate the study subject's ability to use the mobile phone? Response options: * Good * Manageable * Less good

Usability Questionnaire - Question 2

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 2. How did you perceive the study subject's ability to follow the instructions given by Previct Drugs? Response options: * Very good * Good * Either good or bad * Difficult * Very difficult

Usability Questionnaire - Question 4

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 4. How did the study subject experience to put him/herself in the right position to be able to start a test? Response options: * Very easy * Easy * Either easy or difficult * Difficult * Very difficult

Usability Questionnaire - Question 6

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 6. How would you evaluate the study subject's ability to perform a Cross-eyes test? Response options: * Very easy * Easy * Either easy or difficult * Difficult * Very difficult

Usability Questionnaire - Question 8

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 8. How would you evaluate the study subject's ability to perform a Nystagmus test? Response options: * Very easy * Easy * Either easy or difficult * Difficult * Very difficult

Usability Questionnaire - Question 10

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 10. How would you evaluate the study subject's ability to perform a Contraction Test? Response options: * Very easy * Easy * Either easy or difficult * Difficult * Very difficult

Usability Questionnaire - Question 12.

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 12. How did the study subject experience keeping the phone still during the test? Response options: * Very easy * Easy * Either easy or difficult * Difficult * Very difficult

Usability Questionnaire - Question 14.

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 14. In addition to the basic instructions, did the study subject need additional support performing tests with Previct Drugs? Response options: * Yes * No * Partly

Usability Questionnaire - Question 16.

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 16. Was the study subject able to perform the test after receiving additional support? Response options: * Yes * No * Partly

Usability Questionnaire - Question 17.

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 17. How many efforts did it take the study subject to perform test with Previct Drugs? Response options: * 1-2 times * 3-4 times * More than 4 times

Usability Questionnaire - Question 18.

Time Frame: Day 0 (Visit 1)

Observation of a study subject during a test with Previct Drugs through answering a usability questionnaire consisting of 18 usability questions. Question 18. How likely do you think it is that the study subject will be able to perform tests with Previct Drugs without assistance in a home environment? Response options: * Very likely * Likely * Neither likely nor unlikely * Unlikely * Very unlikely

Secondary Outcomes

  • Evaluate if Self-administered Pupillometry Using a Mobile Phone Application Can be Used to Collect Pupillograms for Patients With Substance Use Disorder.(Up to 4 weeks post baseline)
  • Evaluate if Self-administered Pupillometry Using a Mobile Phone Application, After Refinement, Can be Used to Collect Pupillograms From Patients With Substance Use Disorder.(Up to 4 weeks post baseline)

Study Sites (1)

Loading locations...

Similar Trials